News Search Results
Jun 25, 2026, 08:35 ET Chonnam National University Identifies Dual-Function Rice Gene That Boosts Drought Tolerance and Grain Yield
Plant Biotechnology Journal.OsFeSOD3 encodes a chloroplast-localized iron superoxide dismutase, an enzyme known for detoxifying reactive oxygen
More news about: Chonnam National University
Jun 25, 2026, 08:02 ET Lakewood-Amedex Biotherapeutics Announces World-Renowned Expert David G. Armstrong, M.D., Ph.D., as Study Chair for Phase 2a Trial of Nu-3 in Infected Diabetic Foot Ulcers
Lakewood-Amedex Biotherapeutics Inc., (NASDAQ: LABT, the "Company"), a clinical-stage biotechnology company advancing a novel class of potent, fast-acting, broad-spectrum antimicrobials for infectious diseases called the Bisphosphocin®
More news about: Lakewood-Amedex Biotherapeutics Inc.
Jun 25, 2026, 08:00 ET Deloitte Survey: Life Sciences Confidence Rises at Company Level, Despite External Considerations
Solutions and Deloitte Global surveyed 150 life sciences C-suite and senior executives — 90 from biopharma and 60 from medtech — from pharmaceutical, biotechnology, biosimilar, and medical device manufacturing companies across the United States, Europe and Asia in April 2026. The Center also analyzed Q1 2026
More news about: Deloitte LLP
Jun 25, 2026, 06:45 ET What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management
pioneering life-changing discoveries for 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Jun 25, 2026, 06:10 ET Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets
company generated over $1.2 billion in net sales. Its more than 500,000 products are used globally by academic researchers, biopharmaceutical and biotechnology companies, and clinical diagnostic laboratories.For more information on Bio‑Techne, please visit
More news about: Bio-Techne Corporation
Jun 25, 2026, 02:23 ET Innovative Molecules Announces First Patient Dosed in Phase 2a Trial of Adibelivir (IM-250), Advancing Company into Late-Stage Clinical Development
MUNICH, June 25, 2026 /PRNewswire/ -- Innovative Molecules GmbH, a late-stage clinical biotechnology company focused on the development of differentiated antiviral therapies, today announced that the first patient has been dosed in its Phase 2a
More news about: Innovative Molecules GmbH
Jun 25, 2026, 02:20 ET Innovative Molecules Announces First Patient Dosed in Phase 2a Trial of Adibelivir (IM-250), Advancing Company into Late-Stage Clinical Development
MUNICH, June 25, 2026 /PRNewswire/ -- Innovative Molecules GmbH, a late-stage clinical biotechnology company focused on the development of differentiated antiviral therapies, today announced that the first patient has been dosed in its Phase 2a
More news about: Innovative Molecules GmbH
Jun 25, 2026, 02:00 ET Circulate Health announces exclusive partnership with Reborne to bring its advanced therapeutic plasma exchange protocols to UK for first time
Circulate Health and Reborne have today announced an exclusive partnership that will see Reborne become the first UK hospital to offer the American biotechnology company's therapeutic plasma exchange (TPE) procedures. The agreement also marks Circulate Health's first partnership in Europe.TPE is a
More news about: Reborne; Circulate Health
Jun 24, 2026, 14:04 ET Proliant Health & Biologicals Raises the Albumin Standard with AlbufreeDX: Consistent, Animal-Free Recombinant Human Albumin
Headquartered in Ankeny, Iowa, with manufacturing locations in the United States and New Zealand, Proliant continues to expand its capabilities to support biotechnology, diagnostics, and healthcare markets.Albumin is widely used in diagnostics, biopharmaceutical manufacturing, and research workflows for its
More news about: Proliant Health and Biologicals
Jun 24, 2026, 14:00 ET Biosidus Expands its International Footprint Through Strategic Partnership with Mubadala Bio in the UAE
BUENOS AIRES, Argentina, June 24, 2026 /PRNewswire/ -- Biosidus, one of Latin America's pioneering biotechnology companies, announced the signing of a licensing and supply agreement with Mubadala Bio, the life sciences platform of Mubadala Investment Company,
More news about: Biosidus
Jun 24, 2026, 13:47 ET Proliant Health & Biologicals Raises the Albumin Standard with AlbufreeDX: Consistent, Animal-Free Recombinant Human Albumin
Headquartered in Ankeny, Iowa, with manufacturing locations in the United States and New Zealand, Proliant continues to expand its capabilities to support biotechnology, diagnostics, and healthcare markets.Albumin is widely used in diagnostics, biopharmaceutical manufacturing, and research workflows for its
More news about: Proliant Health and Biologicals
Jun 24, 2026, 13:39 ET AI in Healthcare Market to Reach USD 505.6 Billion by 2033, Driven by Rapid Adoption of AI-Powered Clinical Solutions and Digital Healthcare Transformation
recruitment, accelerating data analysis, and supporting faster development of medical innovations. AI technologies are helping pharmaceutical and biotechnology companies analyze complex biological data and enhance research efficiency.Growing Adoption of AI in Precision Medicine and Personalized
More news about: Grand View Research, Inc
Jun 24, 2026, 10:30 ET Digital Pathology Market worth $2.86 billion by 2031 | MarketsandMarkets™
quantification have become faster and more consistent. In March 2025, an article published in Black Book Research reported that more than 70% of biotechnology and life sciences companies now use digital pathology for drug development and biomarker analysis, underscoring its growing importance beyond traditional
More news about: MarketsandMarkets
Jun 24, 2026, 09:25 ET BIO Asia-Taiwan Investment Summit to Showcase 27 Startups Before Global Investors
market, Asia's biotech investment sector is bucking the trend, with fundraising and licensing deal values reaching record highs. Asia's premier biotechnology event, BIO Asia–Taiwan 2026, will be held July 15–19 at the Taipei Nangang Exhibition Center (TaiNEX 1 and 2), with this year's Investment Summit
More news about: Taiwan Bio Industry Organization
Jun 24, 2026, 09:21 ET EP3M Summit 2026 Brings Together Biopharma Leaders to Advance Portfolio Strategy, Decision Intelligence, and Innovation Portfolio Management
place September 29–30, 2026, in Boston and virtually. Now in its twentieth year, EP3M brings together senior leaders from across pharmaceutical and biotechnology organizations to explore practical approaches to portfolio strategy, governance, analytics, prioritization, and investment decision-making.
More news about: Cambridge Healthtech Institute
Jun 24, 2026, 09:00 ET Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation
Consolidation with the Cayman Islands Registrar of Companies.About Virax Biolabs Group LimitedVirax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is developing T cell-based test technologies
More news about: Virax BioLabs Group Limited
Jun 24, 2026, 08:45 ET Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
pioneering life-changing discoveries for 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Jun 24, 2026, 08:37 ET Rocket One Regains Full Nasdaq Compliance with Minimum Bid Price Requirement
value as we advance our technology portfolio and strategic initiatives."Rocket One recently announced its corporate transformation from a biotechnology-focused organization into a technology platform centered on next-generation computing architectures, including licensed spintronic and nanomagnetic
More news about: Rocket One Inc.
Jun 24, 2026, 08:00 ET IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine
MILFORD, Mass., June 24, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) and IMU Biosciences, a biotechnology company decoding the immune system to pioneer a paradigm shift in how we understand, diagnose, and treat disease, today announced a strategic partnership
More news about: Waters Corporation
Jun 24, 2026, 08:00 ET IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine
MILFORD, Mass., June 24, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) and IMU Biosciences, a biotechnology company decoding the immune system to pioneer a paradigm shift in how we understand, diagnose, and treat disease, today announced a strategic partnership
More news about: Waters Corporation
Jun 24, 2026, 07:05 ET REGENXBIO Completes Dosing in Confirmatory Study of RGX-202, Marking Completion of Registrational Development Program and Supporting Planned BLA Submission in Q3 2026
support for breathing, cardiomyopathy and premature death.ABOUT REGENXBIO Inc.REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field
More news about: REGENXBIO Inc.
Jun 24, 2026, 03:58 ET EQT Life Sciences participates in RQ Bio's USD 115 million Series A financing
TherapeuticsEQT Life Sciences is pleased to announce participation in a USD 115 million (GBP 86 million) Series A financing in RQ Bio, a UK biotechnology company developing antibody therapies for the prevention of influenza in high-risk and immunocompromised populations through one of its managed
More news about: EQT
Jun 24, 2026, 02:04 ET UniXell Biotechnology Secures FDA IND Clearance for UX-DA003, Achieving China-U.S. Dual Breakthrough in iPSC Parkinson's Therapy
arrangement will strongly underpin the global rollout of the company's allogeneic cell therapy pipeline.About UniXell BiotechnologyUniXell Biotechnology Co., Ltd. is a leading innovative biotech company focusing on the research and clinical transformation of iPSC-based regenerative
More news about: Unixell Biotech
Jun 23, 2026, 19:03 ET Abu Dhabi Opens Strategic Life Sciences Corridor to California Through Biocom Partnership
of the healthcare sector in Abu Dhabi, and Biocom California, one of the world's largest life sciences associations representing more than 1,800 biotechnology, pharmaceutical and medical technology organisations, have announced a strategic partnership that will create a formal gateway between Abu Dhabi
More news about: The Department of Health - Abu Dhabi
Jun 23, 2026, 18:54 ET Abu Dhabi Opens Strategic Life Sciences Corridor to California Through Biocom Partnership
of the healthcare sector in Abu Dhabi, and Biocom California, one of the world's largest life sciences associations representing more than 1,800 biotechnology, pharmaceutical and medical technology organisations, have announced a strategic partnership that will create a formal gateway between Abu Dhabi
More news about: The Department of Health - Abu Dhabi